Zevra Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Zevra Therapeutics, Inc. (ZVRA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-105.51-46.05-41.54-8.56-12.76-24.52-56.47
Depreciation & Amortization6.391.010.940.260.271.960.32
Deferred Income Tax15.370.000.000.000.000.000.00
Stock Based Compensation14.916.184.522.742.690.000.00
Change in Working Capital-6.645.88-4.14-0.360.37-4.35-2.29
Change in Accounts Receivable6.87-9.08-6.771.05-0.710.000.00
Change in Inventory-8.870.210.150.000.000.000.00
Change in Accounts Payable-3.6011.133.13-1.110.930.000.00
Change in Other Working Capital-1.043.633.09-0.300.160.000.00
Other Operating Activities5.82-0.1026.1116.134.933.183.71
Net Cash from Operating Activities-69.67-33.54-18.7210.44-1.94-23.74-54.20
Investing Activities
Capital Expenditures0.00-0.300.09-0.10-0.030.03-0.02
Acquisitions0.00-30.40-14.090.000.000.000.00
Purchases of Investments-41.1613.31-22.54-15.420.000.000.00
Sales/Maturities of Investments25.00-45.81-22.54-15.420.003.2633.35
Other Investing Activities-6.000.000.000.000.000.000.00
Net Cash from Investing Activities-22.16-17.39-36.72-15.52-0.033.2333.33
Financing Activities
Debt Repayment16.29-17.54-0.02-38.10-0.26-0.21-0.19
Common Stock Issued64.526.32-4.72158.242.300.0028.33
Common Stock Repurchased0.00-3.45-4.72-2.810.000.000.00
Other Financing Activities1.300.690.29-4.22-0.120.00-0.18
Net Cash from Financing Activities82.1128.468.35113.112.744.9428.02
Summary
Effect of Forex Changes on Cash0.450.040.200.000.000.000.00
Net Change in Cash-9.26-22.42-46.88108.020.77-15.567.15
Cash at Beginning of Period43.0565.47112.354.323.5619.1211.97
Cash at End of Period33.79-110.0565.47112.354.323.5619.12
Free Cash Flow-69.67-33.83-18.8110.34-1.97-23.76-54.22
Supplemental Disclosures
Interest Paid5.260.460.320.220.085.365.54